Organization
ImmunoScience Development Center, Abbott Laboratories, Parsippany, United States
2 abstracts
Abstract
ADALIMUMAB INHIBITS THE PROGRESSION OF STRUCTURAL JOINT DAMAGE IN PATIENTS WITH ACTIVE RAOrg: Centre for Advanced Therapeutics, Mount Sinai Hospital, Toronto, Canada, Rheumatology Div., UCSD, La Jolla, Bainbridge Island, United States, Rheumatic Disease Centre of Montreal, Montreal, Canada, ImmunoScience Development Center, Abbott Laboratories, Parsippany, United States,
Abstract
ASSESSMENT OF CARTILAGE DEGRADATION AND PROTECTIVE MARKERS IN SYNOVIAL FLUID FROM OSTEOARTHRITIS PATIENTS BEFORE AND AFTER CYCLES OF INTRA-ARTICULAR INJECTIONS WITH SPRIFERMINOrg: Nordic Bioscience, ImmunoScience Development Center, Abbott Laboratories, Parsippany, United States, Herlev Hospital, Denmark, Merck,